[144] Vistra Corp. SEC Filing

Rhea-AI Filing Summary

Vistra Corp. (VST) Form 144 notifies the market that an affiliate intends to sell 21,378 common shares (aggregate market value $4,316,995.03) through Fidelity Brokerage on the NYSE on 09/29/2025. The filing states those shares derive from an option granted on 04/09/2018 and will be paid in cash. The filer also reported a series of open-market dispositions by the same person, James A. Burke, totaling 297,692 shares sold across multiple dates in September 2025, with each trade showing separate gross proceeds. The notice includes the seller's attestation about lack of undisclosed material information and complies with Rule 144 disclosure requirements.

Positive

• Filing compliance: The Form 144 is submitted as LIVE and includes required disclosures about the securities, acquisition date, and planned sale.
• Source disclosed: The securities to be sold are identified as option-derived (option granted 04/09/2018), clarifying acquisition origin.

Negative

• Material insider selling: The same individual reported 297,692 shares sold in September 2025, plus a planned sale of 21,378 shares on 09/29/2025, representing multi-million-dollar dispositions.
• Limited ownership context: The filing does not disclose the seller's remaining beneficial ownership percentage, limiting assessment of impact on insider alignment.

Insights

Securities Analyst

TL;DR: Large insider sales were reported; filings show orderly dispositions rather than a single block sale.

The filing documents a planned sale of 21,378 shares on 09/29/2025 valued at $4.32 million and confirms prior open-market sales by the same individual totaling 297,692 shares during September 2025. From a market-activity perspective, clustered daily sales across multiple dates suggest routine liquidity management or option exercise monetization rather than a single distressed divestiture. The filing includes required attestation under Rule 144, which preserves compliance clarity but does not provide context on holding percentages or post-sale ownership.

Corporate Governance Expert

TL;DR: Disclosure is compliant but lacks contextual ownership details needed for governance assessment.

The Form 144 appropriately discloses the number, source (option granted 04/09/2018), and planned sale date for the 21,378 shares and lists multiple recent transactions by the same person. While this meets SEC Form 144 content requirements, it does not state the seller's remaining ownership stake or whether sales follow a pre-established trading plan. Without those details, governance implications for insider alignment with shareholders cannot be fully evaluated.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	21378	4316995.03	338820324	09/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/29/2025	Option Granted - 04/09/2018	Issuer			21378	09/29/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/10/2025	19592	3933635.75
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/11/2025	43074	8991625.77
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/12/2025	21374	4335603.72
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/15/2025	21362	4481773.62
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/16/2025	21358	4565882.26
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/17/2025	21361	4540506.03
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/18/2025	21366	4554708.26
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/19/2025	21360	4517570.62
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/22/2025	21362	4503715.06
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/23/2025	21360	4490151.57
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/24/2025	21371	4355909.13
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/25/2025	21376	4273632.11
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/26/2025	21376	4300490.42

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Vistra Corp. (VST) Form 144 report?

The Form 144 reports a planned sale of 21,378 common shares (aggregate market value $4,316,995.03) on 09/29/2025, and prior September 2025 sales by the same person totaling 297,692 shares.

Who is the seller named in the filing for VST?

The recent transactions and address listed identify James A. Burke as the person selling shares in September 2025.

What is the origin of the shares to be sold on 09/29/2025?

The shares to be sold were acquired via an option granted on 04/09/2018, and payment for the planned sale is listed as cash.

Where will the planned VST sale execute?

The planned sale of 21,378 shares is to be executed through Fidelity Brokerage Services LLC on the NYSE.

Does the Form 144 state whether the seller knows of any undisclosed material information?

Yes. By signing, the seller attests they do not know of any material adverse information about the issuer that has not been publicly disclosed.